145 related articles for article (PubMed ID: 32011562)
21. [Clinicopathological features of notochordal tumors: a study of 48 cases].
Huang J; Yang TT; Jiang ZM; Zhang HZ
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):201-206. PubMed ID: 33677882
[No Abstract] [Full Text] [Related]
22. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas.
Mobley BC; McKenney JK; Bangs CD; Callahan K; Yeom KW; Schneppenheim R; Hayden MG; Cherry AM; Gokden M; Edwards MS; Fisher PG; Vogel H
Acta Neuropathol; 2010 Dec; 120(6):745-53. PubMed ID: 21057957
[TBL] [Abstract][Full Text] [Related]
23. Integrase Interactor 1 (INI-1) Deficient Renal Cell Carcinoma.
Singh M; Singh H; Hambro B; Kaur J; Rao R
Cureus; 2021 Feb; 13(2):e13082. PubMed ID: 33680622
[TBL] [Abstract][Full Text] [Related]
24. Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis.
Hasselblatt M; Thomas C; Hovestadt V; Schrimpf D; Johann P; Bens S; Oyen F; Peetz-Dienhart S; Crede Y; Wefers A; Vogel H; Riemenschneider MJ; Antonelli M; Giangaspero F; Bernardo MC; Giannini C; Ud Din N; Perry A; Keyvani K; van Landeghem F; Sumerauer D; Hauser P; Capper D; Korshunov A; Jones DT; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Kool M
Acta Neuropathol; 2016 Jul; 132(1):149-51. PubMed ID: 27067307
[No Abstract] [Full Text] [Related]
25. Poorly Differentiated Chordomas Showing Loss of INI1/SMARCB1: A Report of 2 Rare Cases With Diagnostic Implications.
Rekhi B; Kosemehmetoglu K; Rane S; Soylemezoglu F; Bulut E
Int J Surg Pathol; 2018 Oct; 26(7):637-643. PubMed ID: 29623728
[TBL] [Abstract][Full Text] [Related]
26. Poorly differentiated chordoma: review of 53 cases.
Yeter HG; Kosemehmetoglu K; Soylemezoglu F
APMIS; 2019 Sep; 127(9):607-615. PubMed ID: 31243811
[TBL] [Abstract][Full Text] [Related]
27. Metastatic SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Fine-Needle Aspiration (EBUS-FNA): A Potential Diagnostic Pitfall and Review of the Literature.
McHugh KE; Policarpio-Nicolas MLC
Acta Cytol; 2019; 63(5):431-437. PubMed ID: 31132763
[TBL] [Abstract][Full Text] [Related]
28. Poorly differentiated chordoma with whole-genome doubling evolving from a SMARCB1-deficient conventional chordoma: A case report.
Curcio C; Cimera R; Aryeequaye R; Rao M; Fabbri N; Zhang Y; Hameed M
Genes Chromosomes Cancer; 2021 Jan; 60(1):43-48. PubMed ID: 32920865
[TBL] [Abstract][Full Text] [Related]
29. The SWI/SNF chromatin-remodeling complex status in renal cell carcinomas with sarcomatoid or rhabdoid features.
Kinoshita F; Kohashi K; Sugimoto M; Takamatsu D; Kiyozawa D; Eto M; Oda Y
Virchows Arch; 2020 Nov; 477(5):651-660. PubMed ID: 32447490
[TBL] [Abstract][Full Text] [Related]
30. Chondroid chordoma of the lateral skull base.
Rossiello R; Ferrara G; Varricchio A; Baldi A; Motta S; Motta G
ORL J Otorhinolaryngol Relat Spec; 2001; 63(2):114-8. PubMed ID: 11244373
[TBL] [Abstract][Full Text] [Related]
31. Brachyury: A sensitive marker, but not a prognostic factor, for skull base chordomas.
Wang K; Tian K; Wang L; Wu Z; Ren C; Hao S; Feng J; Li J; Wan H; Jia G; Zhang L; Zhang J
Mol Med Rep; 2015 Sep; 12(3):4298-4304. PubMed ID: 26099340
[TBL] [Abstract][Full Text] [Related]
32. Chordoma: Immunohistochemical Analysis of Brachury.
Sun HI; Guduk M; Gucyetmez B; Yapicier O; Pamir MN
Turk Neurosurg; 2018; 28(2):174-178. PubMed ID: 28094431
[TBL] [Abstract][Full Text] [Related]
33. Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases.
Miettinen M; Wang Z; Lasota J; Heery C; Schlom J; Palena C
Am J Surg Pathol; 2015 Oct; 39(10):1305-12. PubMed ID: 26099010
[TBL] [Abstract][Full Text] [Related]
34. A recurrent SMARCB1/INI-1-deficient poorly differentiated chordoma in the posterior cranial fossa of a 2-year-old female.
Shi Y; Li J; Ma Y; An L; Li T; Liu B
Pediatr Blood Cancer; 2023 Nov; 70(11):e30591. PubMed ID: 37528670
[No Abstract] [Full Text] [Related]
35. Anaplastic chordoma with loss of INI1 and brachyury expression in a 2-year-old girl.
Chavez JA; Nasir Ud Din ; Memon A; Perry A
Clin Neuropathol; 2014; 33(6):418-20. PubMed ID: 25074874
[No Abstract] [Full Text] [Related]
36. [Chordoma: diagnostic considerations and review of the literature].
Conforti R; Sardaro A; Tecame M; Rossi C; Vargas O; Raucci A; Sica A
Recenti Prog Med; 2013; 104(7-8):322-7. PubMed ID: 24042401
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic characteristics of poorly differentiated chordoma.
Shih AR; Cote GM; Chebib I; Choy E; DeLaney T; Deshpande V; Hornicek FJ; Miao R; Schwab JH; Nielsen GP; Chen YL
Mod Pathol; 2018 Aug; 31(8):1237-1245. PubMed ID: 29483606
[TBL] [Abstract][Full Text] [Related]
38. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
[TBL] [Abstract][Full Text] [Related]
39. SMARCB1 (Integrase Interactor 1)-Deficient Sinonasal Carcinoma of the Maxillary Sinus: A Newly Described Sinonasal Neoplasm.
Shanti RM; Farahi A; Curry JM; Alawi F
J Oral Maxillofac Surg; 2020 Oct; 78(10):1870.e1-1870.e6. PubMed ID: 32619462
[TBL] [Abstract][Full Text] [Related]
40. Cytopathologic features of SMARCB1 (INI-1)-deficient sinonasal carcinoma.
Allard FD; Bell D; Stelow EB
Cancer Cytopathol; 2018 Aug; 126(8):567-574. PubMed ID: 29797680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
